Publications by authors named "Edward Handelsman"

Claim this Profile
P
Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age.
Sharon Nachman, Carmelita Alvero, Edward P Acosta, Hedy Teppler, Brenda Homony, Edward Handelsman

J Pediatric Infect Dis Soc· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raltegravir pharmacokinetics in neonates following maternal dosing.
Diana F Clarke, Edward P Acosta, Matthew L Rizk, Yvonne J Bryson, Stephen A Spector, Edward Handelsman

J Acquir Immune Defic Syndr· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years.
Sharon Nachman, Nan Zheng, Edward P Acosta, Hedy Teppler, Brenda Homony, Edward Handelsman

Clin Infect Dis· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.
Mark F Cotton, Avy Violari, Kennedy Otwombe, Ravindre Panchia, Els Dobbels, Edward Handelsman

Lancet· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
George K Siberry, Mark J Abzug, Sharon Nachman, Michael T Brady, Kenneth L Dominguez, Edward Handelsman

Pediatr Infect Dis J· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088).
Adriana Weinberg, Petronella Muresan, Terence Fenton, Kelly Richardson, Teresa Dominguez, Edward Handelsman

Hum Vaccin Immunother· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women.
Mark J Abzug, Sharon A Nachman, Petronella Muresan, Edward Handelsman, D Heather Watts

Clin Infect Dis· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.
Patricia M Flynn, Sharon Nachman, Petronella Muresan, Terence Fenton, Stephen A Spector, Edward Handelsman

J Infect Dis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.
Myron J Levin, Anna-Barbara Moscicki, Lin-Ye Song, Terrence Fenton, William A Meyer, Edward L Handelsman

J Acquir Immune Defic Syndr· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
Lynne M Mofenson, Michael T Brady, Susie P Danner, Kenneth L Dominguez, Rohan Hazra, Edward Handelsman

MMWR Recomm Rep· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children.
Caroline J Chantry, Margaret M Frederick, William A Meyer, Edward Handelsman, Kenneth Rich

Pediatr Infect Dis J· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study.
Susan E Pacheco, Kenneth McIntosh, Ming Lu, Lynne M Mofenson, Clemente Diaz, Edward Handelsman

J Infect Dis· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy.
Mary E Paul, Charlotte Mao, Manhattan Charurat, Leslie Serchuck, Marc Foca, Edward L Handelsman

J Allergy Clin Immunol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study.
Mary E Paul, Caroline J Chantry, Jennifer S Read, Margaret M Frederick, Ming Lu, Edward L Handelsman

Pediatr Infect Dis J· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms.
Robert Winchester, Jane Pitt, Manhattan Charurat, Laurence S Magder, Harald H H Göring, Edward Handelsman

J Acquir Immune Defic Syndr· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune parameters and morbidity in hard drug and human immunodeficiency virus-exposed but uninfected infants.
Natalie Neu, Robert Leighty, Samuel Adeniyi-Jones, Clemente Diaz, Edward Handelsman

Pediatrics· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents.
Chang-Heok Soh, James M Oleske, Michael T Brady, Stephen A Spector, William Borkowsky, Edward Handelsman

Lancet· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children.
Xavier Sáez-Llorens, Avyi Violari, Carl O Deetz, Richard A Rode, Perry Gomez, Edward Handelsman

Pediatr Infect Dis J· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.
Ellen R Cooper, Manhattan Charurat, Lynne Mofenson, I Celine Hanson, Jane Pitt, Edward Handelsman

J Acquir Immune Defic Syndr· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis